The kg7 Product Lineup Includes:
KG7 CBD GUMMIES: 20mg & 50mg Gummies
KG7 CBD Topicals: 250mg Stick300mg Cream 30mg Travel-Size Cream Packet
KG7 CBD OILS: 500mg Mint CBD OIL
KG7 CBD Drink Mixes: 25mg Burst (Grape Flavor) 25mg Smash (Citrus Flavor)
Reliva is the #1 cbd Brand in Brick and Mortar Channel, as rinked by nielsen.
About RELIVA:
Long-Term PARTNERSHIPS with Leading National Wholesalers and Retailers, RELIVA’s Products Can be Found in Over 20,000 RETAIL Stores. For more information, visit https://relivaCBACBACBS://relivaCBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBACBDACBDACBDACBACBACBAOLBACBDACBDACBDADACBAOLBACBACBACBAOLBAOLBACBDES
About Aurora:
Recreational Markets wherever they are launchd. Learn More at www.auroramj.com and follow us on twitter and linkedin.
Aurora’s Common Shares Trade On the Nasdaq and TSX Under The Symbol "ACB" and is a Constituent of the S & P/TSX Composite Index.
Forward-loging information
", Project", "Intend", "Believe", "Anticipate", "Estimate", "May", "Will", "Potential", "PROPOSED" and Other Similar Words, or Statements That CERTAIN EVENTS "And regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company’s annual information form dated (the "AIF ") and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC’s website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements ACB manufacture and are cautioned not to place undue reliance on such information . The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a ACB manufacture result of new information, future events or otherwise, except as expressly required by applicable securities law.